Home

Roche Canada is committed to advancing research and creating value for Canadian patients. In line with this commitment, Roche supports medical and educational activities organized by healthcare organizations/entities and by patient organizations to enhance and maintain patient care and advance research.

Start your request

Roche also supports the community by providing sponsorship for translational, clinical, and healthcare-related education events including conferences, workshops and journal clubs, individual conference support to healthcare stakeholders, and philanthropic donations. Roche does not accept requests from contract fundraisers.

Learn more about these funding opportunities, including:

Roche is committed to funding high-quality medical research and education initiatives that benefit the healthcare community and aim to improve patient outcomes in Canada. This includes requests for independent medical research projects, independent education initiatives or healthcare fellowships where there is an unmet medical need aligned to Roche’s scientific strategy. In addition, Roche occasionally has active calls for independent medical education grants.

Medical research grants may provide support for scientific, translational or clinical research activities that are not focused on a therapeutic molecule or Roche product. Requests for project funding involving therapeutic molecules or Roche products should be requested as investigator-initiated studies using the IIS Portal rather than the Roche Canada Funding Request Tool.

All requests for medical research and education support require a detailed description and rationale for the initiative, a detailed budget breakdown, description of the target audience as well as project proposal that may include background, research objectives, knowledge/data gaps addressed, impact on improving patient care, expected outcomes and/or plans for dissemination of outcomes. The request must be made on behalf of a Healthcare Organization (HCO) such as a private or public hospital, clinic, laboratory, research institution, foundation, managed care organization, universal or other teaching institution or learned society, or through which one or more HCPs provide services; individuals can not request research or educational support.

Roche is committed to advancing research and creating value for Canadian patients. We recognize that to best support patients, we need to effectively engage with patient organizations to ensure their voice and perspective are considered at all times. A Healthcare-Related Entity (HCE) including privately owned organizations that provide medical education to HCPs, patient organizations, professional congress organizers and publishers may request support from Roche for research and education initiatives. Roche cannot support HCE’s that are controlled or owned by an individual stakeholder or their family member, legal representative, or agent.

Requests should include a detailed description and rationale for the initiative, a detailed budget breakdown, description of the target audience as well as project proposal that may include background, research objectives, knowledge/data gaps addressed, impact on improving patient care, expected outcomes and/or plans for dissemination of outcomes.

Giving back to the community is an essential part of Roche’s partnering philosophy. Roche provides sponsorship support for translational, clinical, and healthcare-related education events, workshops and conferences. These requests may or may not align to one of Roche’s therapeutic areas of interest and may be requested on behalf of either a Healthcare-Related Entity or Healthcare Organization. As a matter of corporate policy, Roche does not provide sponsorship support for fundraising events such as galas, walks, rides, golf tournaments, etc. We encourage you to speak with your Roche representative prior to submission if you have questions regarding sponsorship eligibility.

Requests for sponsorship should include a detailed description and rationale for the initiative, description of the target audience, events dates, location and anticipated audience numbers, agenda or draft agenda, sponsorship package and/or letter of request including details on the tangible benefits to Roche. The request should also include a detailed cost breakdown of how sponsorship funds will be used. For example, room rental, catering, speaker fees, etc., as well as details related to other funders involved in supporting the event.

Roche recognizes the important role we play in ensuring HCPs and other stakeholders have access to educational opportunities and are kept informed of developments in health research, sciences and clinical practice. To support increased exposure, Roche provides individual conference support to HCPs and other stakeholders to attend international conferences and congresses with the ultimate goal of sharing learnings with other Canadians and to improve healthcare for Canadian patients. As per Innovative Medicines Canada (IMC) code, only a limited number of HCPs can be supported to attend each event, Roche will process all requests for the same conference at one time.

Individuals requesting support must provide a detailed outline of the topics, knowledge and information they plan to share upon return, as well as their dissemination plans including format, audience type and approximate number and timeline for dissemination. As per IMC code this can include:

  1. The submission of a report or paper to the supporting Member (Roche);
  2. Through a written report to a specialty society/academic institution; or,
  3. A verbal presentation to health care professionals.

Roche also requires event details such as date and location, description of the main educational focus, agenda or draft agenda and a link to the conference webpage (if applicable). Roche can only support requests for international medical and scientific conferences which are not held in Canada.

Roche’s philanthropy program aims at making a meaningful impact in our communities through both financial support and employee volunteerism. Our efforts have a broad alignment to our organization as a healthcare company, which allows Roche Canada to consider requests that explicitly align with our approach to philanthropy and may not align with Roche’s therapeutic areas of interest.

Requests for philanthropic support should include a detailed description and rationale for the initiative, description of the target audience, detailed budget breakdown, including details related to other funders’ involvement, and a detailed description of volunteer opportunities. As a matter of corporate policy, Roche does not provide support for fundraising events such as galas, walks, rides, golf tournaments etc. Additionally, Roche cannot support Healthcare-Related Entities or Healthcare Organizations that are controlled or owned by an individual stakeholder or their family member, legal representative, or agent or businesses that have management or financial ties to a Public Officials or the spouse or dependent children of a Public Official.

Requests for initiatives involving clinical, pre-clinical and/or diagnostic activities that may or may not involve Roche’s therapeutic molecules, are not processed through this Roche Canada Funding Request Tool. Please refer to the Roche Funding Opportunities page for more information.

As with all of Roche’s activities, we strive for high performance and integrity. Roche Canada can only consider initiatives within Canada or those that primarily benefit Canadians and adhere to all guidelines relating to ethical business conduct. We do not evaluate or approve requests based on prescribing habits, drug reimbursement status or decisions, or any specific interactions or relationships that Roche may have with the applicant.

Roche seeks to align support with our commitment to serving patients in areas of high unmet medical need and directs investment towards programs and initiatives that have a direct impact on patient-care within our priority areas of business and therapeutic areas of focus.

Roche is currently accepting requests for medical research and education initiatives in the following therapeutic areas.

  • Breast Cancer
  • Cancer Immunotherapy
  • Data, digital and imaging innovation
  • Gastroenterology and Gastroimmunology (including IBD, Crohn's Disease and Ulcerative Colitis) 
  • Hemophilia
  • Idiopathic Pulmonary Fibrosis
  • Lung Cancer
  • Lupus (including Systemic Lupus Erythematous and Lupus Nephritis)
  • Multiple Sclerosis
  • Neuroimmunology
  • Neuro-Rare Conditions (Spinal Muscular Atrophy, Neuromyelitis Optica Spectrum Disorder and Huntington's Disease)
  • Neuroscience 
  • Non-Hodgkin Lymphoma (DLBCL, FL, CLL)
  • Ophthalmology
  • Personalized healthcare / precision oncology / biomarkers / molecular informatics
  • Rheumatology

Roche is further committed to supporting brand agnostic medical and educational requests that support healthcare system readiness, novel approaches to patient care, clinical capabilities and capacity as well as increased investment in personalized healthcare and real-world evidence. Requests for sponsorship, individual conference support, and philanthropic donations do not need to align with the therapeutic areas above.

Every request received will be evaluated for alignment with Roche’s funding policy, recipient eligibility and adherence to business principles including compliance with both Innovative Medicines Canada (IMC) code and Roche’s business principles. Unfortunately, Roche is not able to support all requests received. In order for requests to be properly evaluated and to ensure that all relevant requirements are met, it is important that the requestor provides full information about the proposed initiative. This includes, but is not limited to, a detailed itemized budget breakdown, description and rationale for the initiative, description and impact on the target audience, letter of request, project proposal and/or sponsorship package.

Each request received will be evaluated separately. Previous support by Roche for a similar request does not guarantee future support. Depending on the nature of the request, partial support may be provided. It is recommended that applications are submitted as early as possible to provide Roche sufficient time to fully review your request. All contracting must be in place before the activity begins.

If you have any questions please contact your Roche representative or submit an inquiry using this link.